tiprankstipranks
Nymox Pharmaceutical (NYMXF)
OTHER OTC:NYMXF
US Market
NYMXF
Nymox Pharmaceutical
RESEARCH TOOLSreports
Want to see NYMXF full AI Analyst Report?

Nymox Pharmaceutical (NYMXF) Income Statement

142 Followers

Nymox Pharmaceutical Income Statement

Last quarter (Q4 2024), Nymox Pharmaceutical's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Nymox Pharmaceutical's net income was $-857.00K. See Nymox Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Mar 23Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00-
Gross Profit
$ -1.00K$ -11.00K$ -12.00K$ -12.00K-
Operating Expenses
$ 4.28M$ 8.34M$ 6.64M$ 12.49M$ 11.71M
Depreciation and Amortization
$ 1.00K$ 11.00K$ 12.00K$ 12.00K-
EBITDA
$ -4.26M$ -8.77M$ -6.52M$ -12.49M$ -11.71M
Operating Income
$ -4.28M$ -8.35M$ -6.65M$ -12.50M$ -11.72M
Other Income/Expenses
$ -209.00K$ -494.00K$ 76.00K$ -33.00K$ -18.00K
Pretax Income
$ -4.49M$ -8.84M$ -6.58M$ -12.54M$ -11.74M
Net Income
$ -4.49M$ -8.84M$ -6.58M$ -12.54M$ -11.74M
Per Share Metrics
Basic EPS
$ -0.05$ -0.10$ -0.07$ -0.15$ -0.16
Diluted EPS
$ -0.05$ -0.10$ -0.07$ -0.15$ -0.16
Weighted Average Shares Outstanding
 93.67M 91.69M 89.38M 81.98M 73.82M
Weighted Average Shares Outstanding (Diluted)
 93.67M 91.69M 89.38M 81.98M 73.82M
Currency in USD

Nymox Pharmaceutical Earnings and Revenue History